These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 25061467)

  • 1. Uric Acid Puzzle: Dual Role as Anti-oxidantand Pro-oxidant.
    Kang DH; Ha SK
    Electrolyte Blood Press; 2014 Jun; 12(1):1-6. PubMed ID: 25061467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uric acid and chronic renal disease: possible implication of hyperuricemia on progression of renal disease.
    Kang DH; Nakagawa T
    Semin Nephrol; 2005 Jan; 25(1):43-9. PubMed ID: 15660334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary Antioxidant Supplements and Uric Acid in Chronic Kidney Disease: A Review.
    Roumeliotis S; Roumeliotis A; Dounousi E; Eleftheriadis T; Liakopoulos V
    Nutrients; 2019 Aug; 11(8):. PubMed ID: 31443225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into uric acid effects on the progression and prognosis of chronic kidney disease.
    Filiopoulos V; Hadjiyannakos D; Vlassopoulos D
    Ren Fail; 2012; 34(4):510-20. PubMed ID: 22260409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress.
    Sautin YY; Nakagawa T; Zharikov S; Johnson RJ
    Am J Physiol Cell Physiol; 2007 Aug; 293(2):C584-96. PubMed ID: 17428837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic insights into hyperuricemia-associated renal abnormalities with special emphasis on epithelial-to-mesenchymal transition: Pathologic implications and putative pharmacologic targets.
    Balakumar P; Alqahtani A; Khan NA; Mahadevan N; Dhanaraj SA
    Pharmacol Res; 2020 Nov; 161():105209. PubMed ID: 32979505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperuricemia, the kidneys, and the spectrum of associated diseases: a narrative review.
    Jalal DI
    Curr Med Res Opin; 2016 Nov; 32(11):1863-1869. PubMed ID: 27470664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of hyperuricemia in vascular disorders.
    Edwards NL
    Curr Opin Rheumatol; 2009 Mar; 21(2):132-7. PubMed ID: 19339923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct radical scavenging activity of benzbromarone provides beneficial antioxidant properties for hyperuricemia treatment.
    Kadowaki D; Sakaguchi S; Miyamoto Y; Taguchi K; Muraya N; Narita Y; Sato K; Chuang VT; Maruyama T; Otagiri M; Hirata S
    Biol Pharm Bull; 2015; 38(3):487-92. PubMed ID: 25757933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of xanthine oxidoreductase and uric acid in metabolic syndrome.
    Battelli MG; Bortolotti M; Polito L; Bolognesi A
    Biochim Biophys Acta Mol Basis Dis; 2018 Aug; 1864(8):2557-2565. PubMed ID: 29733945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for uric acid in the progression of renal disease.
    Kang DH; Nakagawa T; Feng L; Watanabe S; Han L; Mazzali M; Truong L; Harris R; Johnson RJ
    J Am Soc Nephrol; 2002 Dec; 13(12):2888-97. PubMed ID: 12444207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uric acid as one of the important factors in multifactorial disorders--facts and controversies.
    Pasalic D; Marinkovic N; Feher-Turkovic L
    Biochem Med (Zagreb); 2012; 22(1):63-75. PubMed ID: 22384520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uric acid and inflammation in kidney disease.
    Jung SW; Kim SM; Kim YG; Lee SH; Moon JY
    Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1327-F1340. PubMed ID: 32223310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Pathophysiology of Uric Acid on Renal Diseases.
    Sánchez-Lozada LG
    Contrib Nephrol; 2018; 192():17-24. PubMed ID: 29393088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The uric acid cardio-nephropathy].
    Viazzi F; Bonino B; Cappadona F; Pontremoli R
    G Ital Nefrol; 2017 Mar; 34(Suppl 69):41-48. PubMed ID: 28682028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The paradoxical relationship between serum uric acid and cardiovascular disease.
    Lippi G; Montagnana M; Franchini M; Favaloro EJ; Targher G
    Clin Chim Acta; 2008 Jun; 392(1-2):1-7. PubMed ID: 18348869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Oxidative Stress in Hyperuricemia and Xanthine Oxidoreductase (XOR) Inhibitors.
    Liu N; Xu H; Sun Q; Yu X; Chen W; Wei H; Jiang J; Xu Y; Lu W
    Oxid Med Cell Longev; 2021; 2021():1470380. PubMed ID: 33854690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Uric acid as a scavenger in oxidative stress].
    Staub M
    Orv Hetil; 1999 Feb; 140(6):275-9. PubMed ID: 10071505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal regulation of plasma total antioxidant capacity.
    Kirschbaum B
    Med Hypotheses; 2001 Jun; 56(6):625-9. PubMed ID: 11399110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?
    Johnson RJ; Kang DH; Feig D; Kivlighn S; Kanellis J; Watanabe S; Tuttle KR; Rodriguez-Iturbe B; Herrera-Acosta J; Mazzali M
    Hypertension; 2003 Jun; 41(6):1183-90. PubMed ID: 12707287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.